Kailera Therapeutics Logo

Kailera Therapeutics

🇺🇸
KLRA
US4829311020

Kailera Therapeutics is an innovative US-based biotech company specializing in the development of highly effective therapies for obesity and metabolic diseases. Through clinical research and medical excellence, Kailera advances modern approaches to drug discovery to address significant health challenges.

Next Quarterly Earnings

Tuesday, May 25, 2027
Expected

Stock Price

Frequently asked questions

When did Kailera Therapeutics last report quarterly earnings?

Kailera Therapeutics last reported quarterly earnings on 8/12/2026 (Q2 2026). Earnings per share (EPS) came in at -1.09 USD.

How do I add the Kailera Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$1.07
Actual:
Q2 2026
Missed
Estimate:-$0.85
Actual:-$1.09
Difference:-$0.24
Price reaction (1 day):-3.3 %
Price reaction (7 days):-1.5 %
Q1 2026
Missed
Estimate:-$0.80
Actual:-$3,650.00
Difference:-$3,649.20
Price reaction (1 day):+1.6 %
Price reaction (7 days):+4.7 %

Company Information

Name
Kailera Therapeutics
Ticker Symbol
KLRA
ISIN
US4829311020
Country
🇺🇸
USA
Sector